(RBOT) Vicarious Surgical - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US92561V1098

RBOT: Surgical Robots, Robotic Systems

Vicarious Surgical Inc. (NYSE:RBOT) is a pioneer in the field of single-port surgical robotics, revolutionizing minimally invasive surgery with its cutting-edge technology. Founded in 2014 and headquartered in Waltham, Massachusetts, the company has developed the Vicarious Surgical System, which combines virtual reality and haptic feedback to provide surgeons with an immersive experience, allowing them to perform complex procedures with enhanced precision. This innovative approach reduces the need for multiple incisions, thereby minimizing patient recovery time and potential complications. The systems single-port design stands out in the market, offering a less invasive alternative to traditional surgical methods.

The companys commitment to advancing surgical robotics is evident through its focus on enhancing surgical outcomes and patient care. With a strong emphasis on research and development, Vicarious Surgical continues to push the boundaries of medical technology, aiming to make minimally invasive surgery more accessible and effective. For more information, visit their website at https://www.vicarioussurgical.com.

Based on the analysis of and , the 3-month forecast for Vicarious Surgical Inc. (NYSE:RBOT) suggests cautious optimism. The stock is currently trading below its 20-day and 50-day moving averages ($12.81 and $13.26, respectively), indicating potential short-term bearish momentum. However, it remains above the 200-day moving average ($9.60), suggesting underlying support. The Average True Range (ATR) of $1.54 indicates moderate volatility, which may lead to price fluctuations within the forecast period. Given the companys focus on innovation and the potential for regulatory approvals or strategic partnerships, positive developments could drive upward momentum. However, investors should monitor the companys progress closely, as the stocks performance may be influenced by broader market trends and investor sentiment. In conclusion, while the technical indicators present a mixed outlook, the companys fundamental focus on advancing surgical robotics positions it for potential long-term growth. Investors are advised to consider both technical and fundamental factors when making decisions regarding RBOT.

Additional Sources for RBOT Stock

RBOT Stock Overview

Market Cap in USD 49m
Sector Healthcare
Industry Medical Devices
GiC Sub-Industry Health Care Equipment
IPO / Inception 2020-09-04

RBOT Stock Ratings

Growth Rating -68.6
Fundamental -
Dividend Rating 0.0
Rel. Strength 1.6
Analysts 3.67/5
Fair Price Momentum 4.68 USD
Fair Price DCF -

RBOT Dividends

No Dividends Paid

RBOT Growth Ratios

Growth Correlation 3m -73.5%
Growth Correlation 12m 16.7%
Growth Correlation 5y -92.8%
CAGR 5y -52.67%
CAGR/Max DD 5y -0.53
Sharpe Ratio 12m -0.88
Alpha -21.55
Beta 2.300
Volatility 119.13%
Current Volume 11.4k
Average Volume 20d 12.8k
What is the price of RBOT stocks?
As of May 09, 2025, the stock is trading at USD 8.84 with a total of 11,403 shares traded.
Over the past week, the price has changed by +11.19%, over one month by +74.02%, over three months by -29.28% and over the past year by -2.53%.
Is Vicarious Surgical a good stock to buy?
No, based on ValueRay Analyses, Vicarious Surgical (NYSE:RBOT) is currently (May 2025) a stock to sell. It has a ValueRay Growth Rating of -68.58 and therefor a clear technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of RBOT as of May 2025 is 4.68. This means that RBOT is currently overvalued and has a potential downside of -47.06%.
Is RBOT a buy, sell or hold?
Vicarious Surgical has received a consensus analysts rating of 3.67. Therefor, it is recommend to hold RBOT.
  • Strong Buy: 1
  • Buy: 0
  • Hold: 2
  • Sell: 0
  • Strong Sell: 0
What are the forecast for RBOT stock price target?
According to ValueRays Forecast Model, RBOT Vicarious Surgical will be worth about 5.6 in May 2026. The stock is currently trading at 8.84. This means that the stock has a potential downside of -36.54%.
Issuer Forecast Upside
Wallstreet Target Price 10.8 21.6%
Analysts Target Price 11.8 32.9%
ValueRay Target Price 5.6 -36.5%